Zhejiang CONBA Pharmaceutical Co Ltd Cash Flow Reinvestment Rate
Zhejiang CONBA Pharmaceutical Co Ltd cash flow reinvestment rate. Zhejiang CONBA Pharmaceutical Co Ltd (600572) has a Cash Flow Reinvestment Rate of 0.20x as of September 2025, reinvesting CN¥26.90 Million (capex CN¥26.90 Million ) from operating cash flow of CN¥133.43 Million. Explore 600572 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Zhejiang CONBA Pharmaceutical Co Ltd (2003–2025)
Cash flow reinvestment rate of Zhejiang CONBA Pharmaceutical Co Ltd from 2003 to 2025. Historical reinvestment intensity for Zhejiang CONBA Pharmaceutical Co Ltd across 23 annual periods. Explore Zhejiang CONBA Pharmaceutical Co Ltd capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Zhejiang CONBA Pharmaceutical Co Ltd Cash Flow Reinvestment Rate by Year (2003–2025)
Zhejiang CONBA Pharmaceutical Co Ltd cash flow reinvestment rate by year from 2003 to 2025. Year-by-year capital reinvestment analysis for Zhejiang CONBA Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of Zhejiang CONBA Pharmaceutical Co Ltd.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.22x | CN¥203.16 Million | CN¥942.61 Million | CN¥147.26 Million | ▼ -37.5% |
| 2024 | 0.34x | CN¥349.14 Million | CN¥1.01 Billion | CN¥290.63 Million | ▼ -9.3% |
| 2023 | 0.38x | CN¥341.77 Million | CN¥898.64 Million | CN¥209.14 Million | ▲ +13.9% |
| 2022 | 0.33x | CN¥385.99 Million | CN¥1.16 Billion | CN¥291.75 Million | ▼ -59.7% |
| 2021 | 0.83x | CN¥736.86 Million | CN¥889.94 Million | CN¥568.37 Million | ▲ +40.6% |
| 2020 | 0.59x | CN¥736.05 Million | CN¥1.25 Billion | CN¥460.40 Million | ▲ +19.8% |
| 2019 | 0.49x | CN¥454.84 Million | CN¥925.50 Million | CN¥268.79 Million | ▼ -83.6% |
| 2018 | 3.00x | CN¥1.64 Billion | CN¥545.78 Million | CN¥379.63 Million | ▲ +451.1% |
| 2017 | 0.54x | CN¥387.93 Million | CN¥712.27 Million | CN¥291.80 Million | ▼ -39.6% |
| 2016 | 0.90x | CN¥874.41 Million | CN¥969.71 Million | CN¥231.83 Million | ▼ -32.0% |
| 2015 | 1.33x | CN¥1.10 Billion | CN¥831.26 Million | CN¥286.97 Million | ▲ +90.7% |
| 2014 | 0.70x | CN¥429.23 Million | CN¥617.43 Million | CN¥429.23 Million | ▼ -65.7% |
| 2013 | 2.02x | CN¥476.32 Million | CN¥235.36 Million | CN¥476.32 Million | ▲ +107.4% |
| 2012 | 0.98x | CN¥239.76 Million | CN¥245.76 Million | CN¥239.76 Million | ▲ +38.1% |
| 2011 | 0.71x | CN¥133.09 Million | CN¥188.36 Million | CN¥133.09 Million | ▼ -21.3% |
| 2010 | 0.90x | CN¥113.07 Million | CN¥125.93 Million | CN¥113.07 Million | ▲ +158.3% |
| 2009 | 0.35x | CN¥53.32 Million | CN¥153.39 Million | CN¥53.32 Million | ▼ -57.8% |
| 2008 | 0.82x | CN¥81.12 Million | CN¥98.56 Million | CN¥81.12 Million | ▼ -19.5% |
| 2007 | 1.02x | CN¥81.83 Million | CN¥79.98 Million | CN¥81.83 Million | ▲ +10.9% |
| 2006 | 0.92x | CN¥65.67 Million | CN¥71.20 Million | CN¥65.67 Million | ▼ -6.9% |
| 2005 | 0.99x | CN¥116.57 Million | CN¥117.65 Million | CN¥116.57 Million | ▲ +1.7% |
| 2004 | 0.97x | CN¥63.81 Million | CN¥65.47 Million | CN¥63.81 Million | ▲ +61.0% |
| 2003 | 0.61x | CN¥40.34 Million | CN¥66.64 Million | CN¥40.34 Million | — |